Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: Results of the Dummy Run procedure

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 346-351

  Fenton, Paul A ^a,b   Hurkmans, Coen ^c   Gulyban, Akos ^a   Van Der Leer, Jorien ^c   Matzinger, Oscar ^a,d   Poortmans, Philip ^e   Collette, Laurence ^a   Bolla, Michel ^f  

^a EORTC DATA CENTER   (Belgium)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c CATHARINA HOSPITAL   (Netherlands)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e Institute Verbeeten   (Netherlands)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Delineation; Dummy Run; Prostate; Quality assurance; Radiotherapy

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; DOSIMETRY; DUMMY RUN PROCEDURE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY CONTROL;

DELINEATION; DUMMY RUN; PROSTATE; QUALITY ASSURANCE; RADIOTHERAPY;

HUMANS; MALE; ORGANS AT RISK; PRACTICE GUIDELINES AS TOPIC; PROSTATIC NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE; TUMOR BURDEN;

EID: 84881475874     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.04.020     Document Type: Article

References (34)

1. M. Bolla, D. Gonzalez, and P. Warde Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 1997 295 300
2. M. Bolla, T.M. de Reijke, and G. Van Tienhoven Duration of androgen suppression in the treatment of prostate cancer N Engl J Med 360 2009 2516 2527
3. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
4. V. Grégoire, H. Bartelink, and J. Bernier EORTC Radiation Oncology Group: 50 years of continuous accomplishments Eur J Cancer Suppl 10 2012 150 159
5. T. Budiharto, E. Musat, and P. Poortmans Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century Radiother Oncol 88 2008 403 410
6. K. Johansson, J.C. Horiot, and J. Van Dam Quality assurance control in the EORTC cooperative group of radiotherapy. 2. Dosimetric intercomparison 0131 0301V Radiother Oncol 7 1986 269 279
7. J.C. Horiot, K.A. Johansson, and D.G. Gonzalez Quality assurance control in the EORTC cooperative group of radiotherapy. 1. Assessment of radiotherapy staff and equipment. European Organization for Research and Treatment of Cancer Radiother Oncol 6 1986 275 284
8. J. Horiot, J. Bernier, K. Johansson, E. van der Schueren, and H. Bartelink Minimum requirements for quality assurance in radiotherapy Radiother Oncol 29 1993 103 104
9. F. Ataman, P. Poortmans, and J.B. Davis High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991 Eur J Cancer 40 2004 2411 2416
10. O. Matzinger, P. Poortmans, and J.-Y. Giraud Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review Radiother Oncol 90 2009 285 290
11. P.M. Poortmans, J.L. Venselaar, and H. Struikmans The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I-III breast cancer(1) Int J Radiat Oncol Biol Phys 49 2001 1399 1408
12. J.B. Davis, B. Reiner, A. Dusserre, J.-Y. Giraud, and M. Bolla Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run Radiother Oncol 64 2002 65 73
13. A. Dusserre, G. Garavaglia, J.Y. Giraud, and M. Bolla Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy run Radiother Oncol 36 1995 229 234
14. V.E. Kouloulias, J.-Y. Giraud, and B.J. Davis Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run Radiother Oncol 73 2004 11 20
15. F. Ataman, P. Poortmans, R. Stupp, B. Fisher, and R.-O. Mirimanoff Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review Eur J Cancer 40 2004 1724 1730
16. P.M.P. Poortmans, F. Ataman, and J.B. Davis Quality assurance in the EORTC phase III randomised "boost vs. no boost" trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period Radiother Oncol 76 2005 278 284
17. D.C. Weber, P.M.P. Poortmans, and C.W. Hurkmans Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting Radiother Oncol 100 2011 150 156
18. A. Fairchild, E. Aird, and P.A. Fenton EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility Radiother Oncol 103 2012 279 286
19. A. Fairchild, R. Bar-Deroma, and L. Collette Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach Eur J Cancer 48 2012 1048 1054
20. L.F. Cazzaniga, M.A. Marinoni, and A. Bossi Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles Radiother Oncol 47 1998 293 296
21. C. Fiorino, M. Reni, A. Bolognesi, G.M. Cattaneo, and R. Calandrino Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning Radiother Oncol 47 1998 285 292
22. J.E. Livsey, J.P. Wylie, and R. Swindell Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity? Int J Radiat Oncol Biol Phys 60 2004 1076 1081
23. D.M. Mitchell, L. Perry, and S. Smith Assessing the effect of a contouring protocol on postprostatectomy radiotherapy clinical target volumes and interphysician variation Int J Radiat Oncol Biol Phys 75 2009 990 993
24. P. Ost, G. De Meerleer, and T. Vercauteren Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelines Int J Radiat Oncol Biol Phys 81 2011 e143 e149
25. E.L.H. Khoo, K. Schick, and A.W. Plank Prostate contouring variation: can it be fixed? Int J Radiat Oncol Biol Phys 82 2011 1923 1929
26. P. Poortmans, A. Bossi, and K. Vandeputte Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group Radiother Oncol 84 2007 121 127
27. D. Boehmer, P. Maingon, and P. Poortmans Guidelines for primary radiotherapy of patients with prostate cancer Radiother Oncol 79 2006 259 269
28. P. Ost, G. De Meerleer, W. De Gersem, A. Impens, and W. De Neve Analysis of prostate bed motion using daily cone-beam computed tomography during postprostatectomy radiotherapy Int J Radiat Oncol Biol Phys 79 2011 188 194
29. L. Santanam, C. Hurkmans, and S. Mutic Standardizing naming conventions in radiation oncology Int J Radiat Oncol Biol Phys 83 2012 1344 1349
30. K.L. Wiltshire, K.K. Brock, and M.A. Haider Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy Int J Radiat Oncol Biol Phys 69 2007 1090 1099
31. M.A. Sidhom, A.B. Kneebone, and M. Lehman Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group Radiother Oncol 88 2008 10 19
32. J.M. Michalski, C. Lawton, and I. El Naqa Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 76 2010 361 368
33. L.J. Peters, B. O'Sullivan, and J. Giralt Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02 J Clin Oncol 28 2010 2996 3001
34. J.A. Purdy Quality assurance issues in conducting multi-institutional advanced technology clinical trials Int J Radiat Oncol Biol Phys 71 2008 S66 70